FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Letermovir (Prevymis) Injection
Status: Currently in Shortage
»Date first posted: 10/29/2018
»Therapeutic Categories: Antiviral

Expand all

Merck Sharp & Dohme Corp. (Revised 12/02/2019)

Company Contact Information:
800-672-6372

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
480 mg injection (NDC 0006-5004-01) Available

Notice of *New* Requirement to Administer Through a 0.2 Micron Polyethersulfone (PES) In-Line Filter


Dear Health Care Provider Letter
Other
240 mg injection (NDC 0006-5003-01) Available

Dear Health Care Provider Letter


Notice of *New* Requirement to Administer Through a 0.2 Micron Polyethersulfone (PES) In-Line Filter
Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English